Skip to main content
Clinical Trials/NCT00691171
NCT00691171
Completed
N/A

Using an Electronic Health Record-based Intervention and Broad Education Reach Strategies to Improve Quality of Care for GERD and Gastroprotection for Patients on NSAIDs: a Randomized Controlled Trial

AstraZeneca0 sites5,234 target enrollmentJanuary 2007
ConditionsGERD

Overview

Phase
N/A
Intervention
Not specified
Conditions
GERD
Sponsor
AstraZeneca
Enrollment
5234
Primary Endpoint
Diagnoses of GERD
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of the study is to examine the impact of augmented, high-quality physician-coordinated care executed via an electronic health record (EHR)-based intervention on quality of care for gastroesophageal reflux disease (GERD) and for gastroprotection for patients on chronic non-steroidal anti-inflammatory drugs (NSAIDs) at increased risk for upper GI tract ulcers and ulcer related complications.

Registry
clinicaltrials.gov
Start Date
January 2007
End Date
June 2008
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Eligibility as determined by criteria for participation in studies as part of the MQIC
  • Agreement of participating clinical practices to undergo training in the electronic health record (EHR) intervention designed for this study

Exclusion Criteria

  • Based on voluntary participation by MQIC practices, so practices were excluded if they decided to opt out

Outcomes

Primary Outcomes

Diagnoses of GERD

Time Frame: After 12 months of intervention

Prescriptions for gastroprotective medicines in at-risk, chronic NSAID users

Time Frame: After 12 months of intervention

Secondary Outcomes

  • NSAID-related GI complications(After 12 months of intervention)
  • Change in GERD symptoms score(After 12 months of intervention)
  • Prescriptions for GERD medications(After 12 months of intervention)

Similar Trials